ArticleOncoTargets and therapy2020

MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells.

Bei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.